Press Releases

09.30.2015

Pfizer Updates 2015 Financial Guidance Solely to Include Hospira Operations In Financial Results From September 3, 2015 Through Year-End 2015

09.30.2015

Is 50 Really the New 30? Your Immune System May Not Think So

09.25.2015

Pfizer Declares 28-Cent Fourth-Quarter 2015 Dividend

09.24.2015

BIND Therapeutics Announces Pfizer Inc. Exercises Option to Advance Nanoparticle-Based Kinase Inhibitor for Treatment of Solid Tumors

09.23.2015

Pfizer’s Sayana® Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection

09.22.2015

New Centrum® VitaMints® Offer a Refreshingly New Way to Take a Multivitamin

09.21.2015

Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Oral Tofacitinib in Adults with Moderate-to-Severe Ulcerative Colitis

09.18.2015

Pfizer Inc. Announces Results of Early Tenders and Consents in Exchange Offers

09.16.2015

Pfizer Invites Public to View and Listen to Webcast of October 27 Conference Call with Analysts

09.11.2015

Merck KGaA, Darmstadt, Germany and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015

09.09.2015

Evotec enters into licence and collaboration agreement with Pfizer Inc. in tissue fibrosis

09.09.2015

GPCR Consortium Exceeds Goal with Addition of Four New Pharma Members